Non-promoter Manubhai Shah sells 2.75% stake in Bacil Pharma via open market

Ownership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹41.85

prior close

₹41.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-4.4% vs market

Pharmaceuticals peers, median of 163sector-0.6%-4.4% vs sector

On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 4.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.1

10m

+0.1

15m

-0.3

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-0.6-4.4-0.6-4.4

Next day

-1.6-0.9-0.7-0.3-1.2

-5.4+0.1-5.5+0.5-5.8

-4.9+0.3-5.2+0.0-4.9

-4.4+1.2-5.6+0.3-4.7

-4.5+0.8-5.3+1.3-5.8

-9.4+0.3-9.8+0.1-9.5

15d

-12.8-0.2-12.6+1.0-13.7

-36.0+0.6-36.6+0.8-36.8

-73.2+4.7-77.9+1.4-74.6

-37.2+5.4-42.6+5.6-42.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Manubhai Amrutlal Shah, a non-promoter shareholder of Bacil Pharma, sold 3,94,893 equity shares (2.75%) through open market on 23 and 24 June 2026. His holding fell from 18,31,709 shares (12.77%) to 14,36,816 shares (10.02%). The disclosure was filed under SEBI SAST Regulation 29(2).

Likely market impact

Non-promoter trimming stake near 10% threshold; could signal portfolio rebalancing and mild near-term supply pressure on the stock.